-
Congenital Muscular Dystrophy
A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...-
Upcoming Fundraisers
- Minnesota 1/2 Marathon
4 August 2011
St Paul, MN - Ruby's Diner Hosts Cure CMD Fundraiser
19 February 2012
Rolling Hills Estates, CA 90274 - Long Branch 1/2 Marathon
6 May 2012
Long Branch, NJ - Charlie's Take Me Out To The Ballgame!!
8 July 2012
New York - Disneyland 1/2 Marathon
2 September 2012
Anaheim, CA
- Minnesota 1/2 Marathon
-
AVI BioPharma’s Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophy
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced that it received an orphan drug designation from the Committee for Orphan Medical Products of the European Medicines Agency (EMEA) for AVI-5038, a drug candidate being developed by AVI for the treatment of Duchenne Muscular Dystrophy (DMD). DMD is a genetic muscle-wasting disease caused by failure to produce dystrophin...
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.
CureCMD on Twitter